CHEBI:94640 - LY404039

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name LY404039
ChEBI ID CHEBI:94640
Definition An organic heterobicyclic compound that is (1S,5R)-2-thiabicyclo[3.1.0]hexane carrying oxo, oxo, amino, carboxy, and carboxy groups at positions 2, 2, 4S, 4S, and 6S, respectively. It is a potent agonist of group II metabotropic glutamate receptors mGluR2 mGluR3 (Ki = 149 nM and 92 nM, respectively) and exhibits antipsychotic and anxiolytic efficacy in animal models.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C7H9NO6S
Net Charge 0
Average Mass 235.210
Monoisotopic Mass 235.01506
InChI InChI=1S/C7H9NO6S/c8-7(6(11)12)1-15(13,14)4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2-,3-,4+,7+/m1/s1
InChIKey AVDUGNCTZRCAHH-MDASVERJSA-N
SMILES [H][C@@]12[C@@H](C(O)=O)[C@]1([H])S(=O)(=O)C[C@@]2(N)C(O)=O
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): metabotropic glutamate receptor agonist
An agonist that selectively binds to and activates a metabotropic glutamate receptor.
dopamine agonist
A drug that binds to and activates dopamine receptors.
Application(s): antipsychotic agent
Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
anxiolytic drug
Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.
dopamine agonist
A drug that binds to and activates dopamine receptors.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing LY404039 (CHEBI:94640) has role antipsychotic agent (CHEBI:35476)
LY404039 (CHEBI:94640) has role anxiolytic drug (CHEBI:35474)
LY404039 (CHEBI:94640) has role dopamine agonist (CHEBI:51065)
LY404039 (CHEBI:94640) has role metabotropic glutamate receptor agonist (CHEBI:61966)
LY404039 (CHEBI:94640) is a bridged compound (CHEBI:35990)
LY404039 (CHEBI:94640) is a dicarboxylic acid (CHEBI:35692)
LY404039 (CHEBI:94640) is a non-proteinogenic amino acid derivative (CHEBI:83812)
LY404039 (CHEBI:94640) is a organic heterobicyclic compound (CHEBI:27171)
LY404039 (CHEBI:94640) is a sulfone (CHEBI:35850)
IUPAC Name
(1R,4S,5S,6S)-4-amino-2-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid 2,2-dioxide
Synonyms Sources
(−)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid ChEBI
(1R,4S,5S,6S)-4-amino-2,2-dioxo-6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid IUPAC
LY 404039 ChemIDplus
LY-404,039 ChEBI
LY-404039 ChemIDplus
LY404039 ChemIDplus
pomaglumetad ChEBI
Manual Xrefs Databases
8010312 ChemSpider
C21577 KEGG COMPOUND
LSM-5605 LINCS
Pomaglumetad Wikipedia
View more database links
Registry Number Type Source
635318-11-5 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
16678921 PubMed citation Europe PMC
17204749 PubMed citation Europe PMC
17384937 PubMed citation Europe PMC
18424625 PubMed citation Europe PMC
19006848 PubMed citation Europe PMC
20571979 PubMed citation Europe PMC
21847569 PubMed citation Europe PMC
22884896 PubMed citation Europe PMC
23694720 PubMed citation Europe PMC
24486391 PubMed citation Europe PMC
25382826 PubMed citation Europe PMC
25755052 PubMed citation Europe PMC
31308026 PubMed citation Europe PMC
32403118 PubMed citation Europe PMC
Last Modified
06 May 2021